Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
March 7, 2006
Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma
D Lardinois, F J Jung, I Opitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland
P Bunn, D Carbone, J Grim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B Besse, A Adjei, P Baas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2007
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer
G J Weiss, R Rosell, F Fossella, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 8, 2021
LC3A positive "stone like structures" are differentially associated with survival outcomes and CD68 macrophage infiltration in patients with lung adenocarcinoma and squamous cell carcinoma
M Gachechiladze, I Uberall, D Skanderova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2014
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crinò, C Dooms, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2007
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
G D'Addario, D Rauch, R Stupp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2014
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
F Ciardiello, D Arnold, P G Casali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2004
Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial
C Gridelli, C Manegold, P Mali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
M Ghielmini, K Rufibach, G Salles, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
The Journal of Thoracic and Cardiovascular Surgery
|
March 7, 2006
Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma
D Lardinois, F J Jung, I Opitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland
P Bunn, D Carbone, J Grim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B Besse, A Adjei, P Baas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2007
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer
G J Weiss, R Rosell, F Fossella, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 8, 2021
LC3A positive "stone like structures" are differentially associated with survival outcomes and CD68 macrophage infiltration in patients with lung adenocarcinoma and squamous cell carcinoma
M Gachechiladze, I Uberall, D Skanderova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2014
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crinò, C Dooms, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2007
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
G D'Addario, D Rauch, R Stupp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2014
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
F Ciardiello, D Arnold, P G Casali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2004
Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial
C Gridelli, C Manegold, P Mali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
M Ghielmini, K Rufibach, G Salles, et al.
Page
of 8